TriangleNCT00893516 · REGISTRY CONDITION SEARCH
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Found through the registry condition index, not selected as a treatment recommendation. This discovery collection was restricted to studies with posted results.
- Phase
- PHASE2
- Status at capture
- TERMINATED
- Registry last update
- 2024-04-09
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Open the original ClinicalTrials.gov record → · Download preserved record
What did the study report?
Outcomes, safety and baseline populations are separate source sections. Quality-of-life measures appear under their original outcome titles.
Who could take part
- eligibility Criteria
- Inclusion Criteria: * study is closed to enrollment Exclusion Criteria: * study is closed to enrollment
- healthy Volunteers
- false
- minimum Age
- 18 Years
- sex
- ALL
- std Ages
- ADULT
- OLDER_ADULT
Treatment arms and interventions
- arm Groups
- description
- CHOP chemo therapy + CD4 therapy
- intervention Names
- Biological: CHOP + CD4
- label
- 1
- type
- EXPERIMENTAL
- description
- CHOP chemotherapy
- intervention Names
- Drug: CHOP
- label
- 2
- type
- ACTIVE_COMPARATOR
- interventions
- arm Group Labels
- 1
- name
- CHOP + CD4
- type
- BIOLOGICAL
- arm Group Labels
- 2
- name
- CHOP
- type
- DRUG
Study design
- allocation
- RANDOMIZED
- intervention Model
- PARALLEL
- masking Info
- masking
- NONE
- primary Purpose
- TREATMENT
Enrollment
- count
- 5
- type
- ACTUAL
Registered outcome plans (not posted results)
- primary Outcomes
- description
- All efforts to obtain data have been exhausted, therefore we have no data available to report.
- measure
- Primary Outcome Unavailable
Full study description
- brief Summary
- Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Source references
Source notices and limitations
Discovery and provenance
- release id
- ctgov-registry-1336d216cbd1bbff780dac70
- edge id
- nct-edge-1a83ff165332daf3a202
- requested nct id
- NCT00893516
- primary nct id
- NCT00893516
- source kind
- ctgov_condition_query
- source record id
- Source null
- source file sha256
- e270600534699a676fe83226e7a7b0f73aeb00c1d0a05cfc115c748864ad8173
- payload sha256
- b291cabb8fe253d79b18ac82dafc49689f6d83efef51b7700cc48e238f73f43f
- payload
- clinical indication matching status
- condition_index_match_asserted_by_registry_not_reviewed
- end exclusive
- true
- id
- nct-edge-1a83ff165332daf3a202
- link basis
- returned_by_explicit_condition_and_posted_results_filter_query
- nct id
- NCT00893516
- occurrences
- context exact
- NCT00893516
- end
- 11
- exact text
- NCT00893516
- start
- 0
- offset unit
- unicode_code_points
- query cond
- Peripheral T-Cell Non-Hodgkin Lymphoma
- query disease state id
- ds-peripheral-t-cell-non-hodgkin-lymphoma
- source file
- /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-peripheral-t-cell-non-hodgkin-lymphoma-000.json
- source file sha256
- e270600534699a676fe83226e7a7b0f73aeb00c1d0a05cfc115c748864ad8173
- source json pointer
- /studies/33/protocolSection/identificationModule/nctId
- source kind
- ctgov_condition_query
- source record id
- Source null
- source string basis
- parsed_JSON_string_unmodified
- source string sha256
- 6c4ac3fb9c19ffd0d8e27cc789bdfeb3e73674f1092bc22333ab30907c3f8fb0
Preserved source evidence · Not medical advice